Exact Mass: 464.9576

Exact Mass Matches: 464.9576

Found 24 metabolites which its exact mass value is equals to given mass value 464.9576, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

   

Acyclovir triphosphate

{[hydroxy({[hydroxy({2-[(6-hydroxy-2-imino-3,9-dihydro-2H-purin-9-yl)methoxy]ethoxy})phosphoryl]oxy})phosphoryl]oxy}phosphonic acid

C8H14N5O12P3 (464.9852)


   
   
   

8-Acetamido-1,1,1,15,15,15-hexachloropentadeca-3,12-diyne

8-Acetamido-1,1,1,15,15,15-hexachloropentadeca-3,12-diyne

C17H21Cl6NO (464.9754)


   
   

Guanosine 5-diphosphate

guanosine 5-diphosphate sodium salt

C10H14N5NaO11P2 (465.0063)


   

Acyclovir triphosphate

Acyclovir triphosphate

C8H14N5O12P3 (464.9852)


D000890 - Anti-Infective Agents > D000998 - Antiviral Agents D004791 - Enzyme Inhibitors

   

2-(4-Chlorophenyl)-3-[(4-iodophenyl)sulfonyl]-1,3-thiazolidine

2-(4-Chlorophenyl)-3-[(4-iodophenyl)sulfonyl]-1,3-thiazolidine

C15H13ClINO2S2 (464.9121)


   

2-(3,5-Dibromophenyl)-4,6-diphenyl-1,3,5-triazine

2-(3,5-Dibromophenyl)-4,6-diphenyl-1,3,5-triazine

C21H13Br2N3 (464.9476)


   

5-(4-Bromophenyl)-6-{2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy}-4-pyrimidinamine

5-(4-Bromophenyl)-6-{2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy}-4-pyrimidinamine

C16H13Br2N5O2 (464.9436)


   
   

5-oxo-1-(4-sulfonatophenyl)-4-[(4-sulfonatophenyl)diazenyl]-4H-pyrazole-3-carboxylate

5-oxo-1-(4-sulfonatophenyl)-4-[(4-sulfonatophenyl)diazenyl]-4H-pyrazole-3-carboxylate

C16H9N4O9S2-3 (464.9811)


   

5-hydroxy-1-(4-sulfonatophenyl)-4-[(E)-(4-sulfonatophenyl)diazenyl]-1H-pyrazole-3-carboxylate

5-hydroxy-1-(4-sulfonatophenyl)-4-[(E)-(4-sulfonatophenyl)diazenyl]-1H-pyrazole-3-carboxylate

C16H9N4O9S2-3 (464.9811)


   

2-deoxy-5-O-[({[(hydroxyphosphinato)oxy]phosphinato}oxy)phosphinato]uridine

2-deoxy-5-O-[({[(hydroxyphosphinato)oxy]phosphinato}oxy)phosphinato]uridine

C9H12N2O14P3-3 (464.9501)


COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

1-(3,6-Dibromo-9H-carbazol-9-yl)-3-(piperazin-1-yl)propan-2-ol

1-(3,6-Dibromo-9H-carbazol-9-yl)-3-(piperazin-1-yl)propan-2-ol

C19H21Br2N3O (465.0051)


   

N-(5-bromo-2-oxo-3-indolyl)-2-[2-(trifluoromethyl)-1-benzimidazolyl]acetohydrazide

N-(5-bromo-2-oxo-3-indolyl)-2-[2-(trifluoromethyl)-1-benzimidazolyl]acetohydrazide

C18H11BrF3N5O2 (465.0048)


   

4-[4-(3-Bromophenyl)sulfonyl-1-piperazinyl]-7-chloroquinoline

4-[4-(3-Bromophenyl)sulfonyl-1-piperazinyl]-7-chloroquinoline

C19H17BrClN3O2S (464.9913)


   

dUTP(3-)

dUTP(3-)

C9H12N2O14P3 (464.9501)


A 2-deoxyribonucleoside triphosphate oxoanion arising from deprotonation of three of the four triphosphate OH groups of 2-deoxyuridine 5-triphosphate.

   

3-deoxy-3,4-didehydro-CTP

3-deoxy-3,4-didehydro-CTP

C9H14N3O13P3 (464.974)


A pyrimidine 3-deoxyribonucleoside 5-triphosphate resulting from the formal condensation of the 5-hydroxy group of 3-deoxy-3,4-didehydro-cytidine with triphosphoric acid. It is a chain terminator for RNA-dependent RNA polymerases.

   

n-(1,1,1,15,15,15-hexachloropentadeca-3,12-diyn-8-yl)ethanimidic acid

n-(1,1,1,15,15,15-hexachloropentadeca-3,12-diyn-8-yl)ethanimidic acid

C17H21Cl6NO (464.9754)


   

(2e)-3-(3-bromo-4-hydroxyphenyl)-n-{2-[(2-{[hydroxy(methoxy)methylidene]amino}ethyl)disulfanyl]ethyl}-2-(n-hydroxyimino)propanimidic acid

(2e)-3-(3-bromo-4-hydroxyphenyl)-n-{2-[(2-{[hydroxy(methoxy)methylidene]amino}ethyl)disulfanyl]ethyl}-2-(n-hydroxyimino)propanimidic acid

C15H20BrN3O5S2 (465.0028)


   

n-(1,5,5,6,6,7-hexachloropentadeca-1,3-diyn-7-yl)ethanimidic acid

n-(1,5,5,6,6,7-hexachloropentadeca-1,3-diyn-7-yl)ethanimidic acid

C17H21Cl6NO (464.9754)


   

3-(3-bromo-4-hydroxyphenyl)-n-{2-[(2-{[hydroxy(methoxy)methylidene]amino}ethyl)disulfanyl]ethyl}-2-(n-hydroxyimino)propanamide

3-(3-bromo-4-hydroxyphenyl)-n-{2-[(2-{[hydroxy(methoxy)methylidene]amino}ethyl)disulfanyl]ethyl}-2-(n-hydroxyimino)propanamide

C15H20BrN3O5S2 (465.0028)